| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 150,124 | 156,393 | 174,977 | 173,861 | | Cost of Revenue | 125,464 | 111,994 | 136,456 | 136,432 | | | Gross Profit | 24,660 | 44,399 | 38,521 | 37,429 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 15,165 | 14,071 | 19,822 | 18,312 | | Non Recurring | (80) | 2,242 | 362 | 221 | | Others | (688) | 688 | 713 | 760 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 10,263 | 27,398 | 17,624 | 18,136 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 17 | 17 | 21 | 37 | | Earnings Before Interest And Taxes | 10,280 | 27,415 | 17,645 | 18,173 | | Interest Expense | 1,595 | 1,699 | 2,942 | 3,029 | | Income Before Tax | 8,685 | 25,716 | 14,703 | 15,144 | | Income Tax Expense | 2,043 | 10,573 | 8,765 | 6,689 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,642 | 15,143 | 5,938 | 8,455 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,642 | 15,143 | 5,938 | 8,455 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,642 | $15,143 | $5,938 | $8,455 |
|
0.18% Nasdaq 
0.42%
Income Statement
